Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 12, 2005. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to reporting specific share transactions and does not contain financial performance data.
Material Changes
On January 11, 2005, the GlaxoSmithKline Employee Trust ("the GSK Trust") transferred 14,708 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991. The company was advised of these transactions on January 12, 2005.
Outlook, Risks, and Management Commentary
The filing contains no guidance, outlook, management commentary, risks, contingencies, or unusual items. It strictly details the mechanics of the share transfer and the nature of the GSK Trust as a discretionary trust for current and former employees.
Investor Verification Points
- Verify the total number of shares transferred (14,708) and the specific plan involved (SmithKline Beecham Employee Share Option Plan 1991).
- Confirm the status of the GSK Trust as a discretionary trust benefiting employees and former employees.
- Note that three directors (Dr J-P Garnier, Dr T Yamada, and Mr J D Coombe) hold interests in the shares held by the GSK Trust.